PuSH - Publikationsserver des Helmholtz Zentrums München

Huth, C. ; Heid, I.M. ; Vollmert, C. ; Gieger, C. ; Grallert, H. ; Wolford, J.K.* ; Langer, B. ; Thorand, B. ; Klopp, N. ; Hamid, Y.H.* ; Pedersen, O.* ; Hansen, T.* ; Lyssenko, V.* ; Groop, L.* ; Meisinger, C. ; Döring, A. ; Löwel, H. ; Lieb, W.* ; Hengstenberg, C.* ; Rathmann, W.* ; Martin, S.* ; Stephens, J.W.* ; Ireland, H.* ; Mather, H.* ; Miller, G.J.* ; Stringham, H.M.* ; Boehnke, M.* ; Tuomilehto, J.* ; Boeing, H.* ; Möhlig, M.* ; Spranger, J.* ; Pfeiffer, A.* ; Wernstedt, I.* ; Niklason, A.* ; Lopez-Bermejo, A.* ; Fernández-Real, J.M.* ; Hanson, R.L.* ; Gallart, L.* ; Vendrell, J.* ; Tsiavou, A.* ; Hatziagelaki, E.* ; Humphries, S.E.* ; Wichmann, H.-E. ; Herder, C.* ; Illig, T.

IL6 gene promoter polymorphisms and type 2 diabetes: Joint analysis of individual participants' data from 21 studies.

Diabetes 55, 2915-2921 (2006)
DOI
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Several lines of evidence indicate a causal role of the cytokine interleukin (IL)-6 in the development of type 2 diabetes in humans. Two common polymorphisms in the promoter of the IL-6 encoding gene IL6, -174G>C (rs1800795) and -573G>C (rs1800796), have been investigated for association with type 2 diabetes in numerous studies but with results that have been largely equivocal. To clarify the relationship between the two IL6 variants and type 2 diabetes, we analyzed individual data on >20,000 participants from 21 published and unpublished studies. Collected data represent eight different countries, making this the largest association analysis for type 2 diabetes reported to date. The GC and CC genotypes of IL6 -174G>C were associated with a decreased risk of type 2 diabetes (odds ratio 0.91, P = 0.037), corresponding to a risk modification of nearly 9%. No evidence for association was found between IL6 -573G>C and type 2 diabetes. The observed association of the IL6 -174 C-allele with a reduced risk of type 2 diabetes provides further evidence for the hypothesis that immune mediators are causally related to type 2 diabetes; however, because the association is borderline significant, additional data are still needed to confirm this finding. © 2006 by the American Diabetes Association.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
8.028
0.000
68
79
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2006
HGF-Berichtsjahr 2006
ISSN (print) / ISBN 0012-1797
e-ISSN 1939-327X
Zeitschrift Diabetes
Quellenangaben Band: 55, Heft: 10, Seiten: 2915-2921 Artikelnummer: , Supplement: ,
Verlag American Diabetes Association
Verlagsort Alexandria, VA.
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Epidemiology (EPI)
POF Topic(s) 30503 - Chronic Diseases of the Lung and Allergies
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-503900-001
Scopus ID 33750877102
Erfassungsdatum 2006-11-09